Schering Plough news from FierceFinance

Investment bankers tend to be an optimistic lot, convinced that the next big deal is right around the corner. There's hope but not a whole lot more right now. Sure, we've seen some big pharmaceutical... Read more...

There are a lot fewer deals these days. And we've seen some massive change when it comes to investment banks and the mergers and acquisitions league tables. To that list, we can now add law firms.... Read more...

Advisory work on two big drug deals pushed Morgan Stanley to the top of the M&A league tables for the first quarter. The bank advised Wyeth on its $64.5 billion purchase by Pfizer and Schering... Read more...